Industry
CHMP Plenary Meeting Results - May 2009
June 2009 | Industry Trend AnalysisThe European Medicine Association (EMEA)'s Committee for Medicinal Products for Human Use (CHMP) May plenary meeting has resulted in the approval of four new medicinal products, bringing the total number of new products approved in the first five monthly meetings of 2009 to 17. Here BMI examines the details of the positive opinions for new drugs, while providing an overview of approvals for new generic medicines, extension indications and other key
To read the full article, please choose one of the following options:
Subcribers please log in




